Screenshot taken on September 6, 2017
Dupixent Now Approved HCP Banner Ad

Brand: Dupixent (dupilumab), Injection
Parent Company: Sanofi Genzyme
Drug Type: Prescription
Drug Category: Dermatology
Campaign: now-approved
Targeting: HCPs
Patient Website: https://www.dupixent.com/
HCP Website: https://www.dupixenthcp.com/